These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9240238)

  • 21. Some issues in the assessment of epilepsy occurring in the context of learning disability in adults.
    Jenkins LK; Brown SW
    Seizure; 1992 Mar; 1(1):49-55. PubMed ID: 1344321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine in the treatment of epilepsy in people with intellectual disability.
    Besag FM
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():50-6. PubMed ID: 10030433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.
    Mattson RH
    Epilepsia; 1996; 37 Suppl 6():S45-53. PubMed ID: 8941041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical evaluation of persons with mental retardation referred for psychiatric assessment.
    Ryan R; Sunada K
    Gen Hosp Psychiatry; 1997 Jul; 19(4):274-80. PubMed ID: 9327256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug treatment of epilepsy in people with intellectual disability.
    Iivanainen M; Alvarez N
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():iv. PubMed ID: 10030425
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment with antiepileptic agents in patients with mental retardation and multiple handicaps].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 2001 Mar; 121(7):834-5. PubMed ID: 11301710
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables.
    Espie CA; Watkins J; Curtice L; Espie A; Duncan R; Ryan JA; Brodie MJ; Mantala K; Sterrick M
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1485-92. PubMed ID: 14617702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health care, epilepsy and learning disabilities.
    Loughran SJ; O'Brien D
    Nurs Stand; 2001 Feb 14-20; 15(22):33-4. PubMed ID: 12211944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive care of the epilepsy patient--control, comorbidity, and cost.
    Bazil CW
    Epilepsia; 2004; 45 Suppl 6():3-12. PubMed ID: 15315510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus guidelines into the management of epilepsy in adults with an intellectual disability.
    Kerr M; ; Scheepers M; Arvio M; Beavis J; Brandt C; Brown S; Huber B; Iivanainen M; Louisse AC; Martin P; Marson AG; Prasher V; Singh BK; Veendrick M; Wallace RA
    J Intellect Disabil Res; 2009 Aug; 53(8):687-94. PubMed ID: 19527434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of side effects of anti-epileptic drugs (AEDs) in adults with intellectual disability: A systematic review.
    Copeland L; Meek A; Kerr M; Robling M; Hood K; McNamara R
    Seizure; 2017 Oct; 51():61-73. PubMed ID: 28806588
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of sulthiame with disturbed mentally subnormal patients.
    Moffatt WR; Siddiqui AR; MacKay DN
    Br J Psychiatry; 1970 Dec; 117(541):673-8. PubMed ID: 4395345
    [No Abstract]   [Full Text] [Related]  

  • 34. [Specifics in the treatment of epilepsy in children with mental retardation].
    Gavranović M; Zubcević S; Anić O; Buljina A
    Med Arh; 1991; 45(3-4):101-2. PubMed ID: 1366326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions.
    Brenner J; Majoie HJM; van Beek S; Carpay JA
    Seizure; 2017 Nov; 52():123-130. PubMed ID: 29031193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catastrophic epilepsy in childhood.
    Shields WD
    Epilepsia; 2000; 41 Suppl 2():S2-6. PubMed ID: 10885734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptics and epilepsy in mentally handicapped patients.
    James DH
    J Ment Defic Res; 1986 Jun; 30 ( Pt 2)():185-9. PubMed ID: 2874230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda.
    Wagner AK; Vickrey BG
    Qual Life Res; 1995 Apr; 4(2):169-77. PubMed ID: 7780383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients.
    Chudnow RS; Dewey RB; Lawson CR
    Arch Neurol; 1997 Jul; 54(7):910-2. PubMed ID: 9236582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing therapy of seizures in children and adolescents with developmental disabilities.
    Smith MC
    Neurology; 2006 Dec; 67(12 Suppl 4):S52-5. PubMed ID: 17190924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.